J. Safra Sarasin Holding’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.18M Sell
29,655
-686
-2% -$68K 0.05% 202
2026
Q1
$2.85M Buy
30,341
+21,935
+261% +$2.19M 0.05% 165
2025
Q4
$830K Sell
8,406
-35,655
-81% -$3.45M 0.01% 344
2025
Q3
$3.74M Buy
+44,061
New +$3.48M 0.06% 155
2024
Q4
Sell
-25,998
Closed -$1.72M 485
2024
Q3
$1.72M Sell
25,998
-815
-3% -$52K 0.03% 239
2024
Q2
$1.63M Buy
+26,813
New +$1.52M 0.03% 248

Other funds holding INCY

J. Safra Sarasin Holding's INCY Position: Q2 2026 in Review

J. Safra Sarasin Holding reduced its Incyte (INCY) stake by 2.3% in Q2 2026, selling an estimated $68K and leaving 29,655 shares worth $3.18M. The position accounts for 0.05% of the portfolio, ranked #202.

J. Safra Sarasin Holding first reported a position in INCY in Q2 2024 and has held it in 6 quarters since. The position peaked at $3.74M in Q3 2025. 853 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • J. Safra Sarasin Holding held 29,655 shares of Incyte worth $3.18M as of Q2 2026.
  • J. Safra Sarasin Holding sold 686 Incyte shares in Q2 2026, an estimated $68K.
  • Incyte made up 0.05% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #202 holding.
  • J. Safra Sarasin Holding first reported a position in Incyte in Q2 2024 and has held it in 6 quarters since.
  • J. Safra Sarasin Holding's Incyte position peaked at $3.74M in Q3 2025.
  • 853 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.